Cas:15294-81-2 4,5-Dibromo-1H-1,2,3-triazole manufacturer & supplier

Chemical Name:4,5-Dibromo-1H-1,2,3-triazole

CAS.NO:15294-81-2

Synonyms:1H-1,2,3-triazole,4,5-dibromo;4,5-dibromo-1H-triazole;4,5-dibromo-1H-[1,2,3]triazole;4,5-dibromo-2H-triazole;v-Triazole,4,5-dibroMo-(8CI);4,5-Dibrom-1H-[1,2,3]triazol;4,5-Dibromo-1H-1,2,3-triazole;4,5-dibromo-1,2,3-triazole;4,5-dibromo-2H-1,2,3-triazole;1H-1,2,3-Triazole, 4,5-dibromo-

Molecular Formula:C₂HBr₂N₃

Molecular Weight:226.857

HS Code:2933990090

Physical and Chemical Properties:

Melting point:35-36ºC

Boiling point:347.5±22.0 °C at 760 mmHg

Density:2.6±0.1 g/cm3

Index of Refraction:1.668

PSA:41.57000

Exact Mass:224.853714

LogP:2.44

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-1,2,3-triazole,4,5-dibromo chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-1,2,3-Triazole, 4,5-dibromo- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,5-dibromo-2H-1,2,3-triazole Use and application,4,5-Dibrom-1H-[1,2,3]triazol technical grade,usp/ep/jp grade.

Related News: The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). 4,5-Dibromo-1H-1,2,3-triazole manufacturer With the onset of the DMF system for APIs, the concentration of the API industry will further increase. 4,5-Dibromo-1H-1,2,3-triazole supplier Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact. 4,5-Dibromo-1H-1,2,3-triazole vendor With the onset of the DMF system for APIs, the concentration of the API industry will further increase. 4,5-Dibromo-1H-1,2,3-triazole factory The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).